financetom
Business
financetom
/
Business
/
LSL Pharma to Raise $4.5 Million Via Private Placements
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LSL Pharma to Raise $4.5 Million Via Private Placements
Jun 5, 2024 7:19 AM

10:02 AM EDT, 06/05/2024 (MT Newswires) -- LSL Pharma Group ( LPGIF ) , a Canadian pharmaceutical company, said on Wednesday that it plans to raise $4.5 Million via a combination of private placements.

LSL intends to raise a maximum of $3 million via a non-brokered private placement financing of 7.5 million units; and is in talks with its creditors to settle debts in about 3.8 million units for up to $1.5 million.

Each unit to be issued under the financing and the units for debts will be priced at $0.40 apiece and will consist of one class A share of the company and one common share purchase warrant. Each warrant will allow the holder to buy one common share at $0.70 for 24 months following the closing of the financing.

The company, which fell near 5% yesterday, was down more than 3% on last look on Wednesday in Canada.

Price: 0.47, Change: -0.02, Percent Change: -3.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vermilion Closes US$400 Million Senior Unsecured Notes Offering
Vermilion Closes US$400 Million Senior Unsecured Notes Offering
Feb 11, 2025
11:17 AM EST, 02/11/2025 (MT Newswires) -- Vermilion Energy ( VET ) on Tuesday said it closed its US$400 million private offering of eight-year senior unsecured notes. The notes mature on Feb. 15, 2033 and have a fixed coupon of 7.250% per annum. The company's shares were last seen up $0.39 to $13.97 on the Toronto Stock Exchange. Price: 13.96,...
Fidelity National Information's Quarterly Revenue, 2025 Top-Line Outlook Miss Views
Fidelity National Information's Quarterly Revenue, 2025 Top-Line Outlook Miss Views
Feb 11, 2025
11:19 AM EST, 02/11/2025 (MT Newswires) -- Shares of Fidelity National Information Services ( FIS ) plunged intraday Tuesday after the financial technology company's top-line performance for the fourth quarter and its top-line outlook for the full year disappointed Wall Street's expectations. Revenue rose to $2.6 billion for the three months ended Dec. 31 from $2.51 billion a year ago,...
Moleculin Biotech Receives Approval in Ukraine to Start Recruiting for Acute Myeloid Leukemia Phase 3 Trial
Moleculin Biotech Receives Approval in Ukraine to Start Recruiting for Acute Myeloid Leukemia Phase 3 Trial
Feb 11, 2025
11:18 AM EST, 02/11/2025 (MT Newswires) -- Moleculin Biotech ( MBRX ) said Tuesday it received regulatory approval in Ukraine to start recruiting for a phase 3 trial of annamycin plus cytarabine to treat relapsed or refractory acute myeloid leukemia, a type of cancer. The first 75 to 90 subjects in the trial's part A will receive high-dose cytarabine, or...
Palo Alto Networks Seeing Higher Momentum as Growth Seeds Lined Up for H2, Wedbush Says
Palo Alto Networks Seeing Higher Momentum as Growth Seeds Lined Up for H2, Wedbush Says
Feb 11, 2025
11:18 AM EST, 02/11/2025 (MT Newswires) -- Palo Alto Networks ( PANW ) is seeing higher momentum in the business around its cybersecurity platformization strategy and the growth seeds are now lined up for a very important H2, Wedbush said in a Tuesday note. The company is expected to provide a strong cybersecurity deal activity when it posts fiscal Q2...
Copyright 2023-2026 - www.financetom.com All Rights Reserved